Constellation Pharmaceuticals Inc
CNSTDelisted Jul 15, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434418
Constellation Pharmaceuticals Inc was delisted on Jul 15, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 153 institutions reported holding it in 13F filings for Q2 2021, worth $1.48B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 153
- Q2 2021, +21 vs. previous quarter
- 13F value
- $1.48B
- Reported value at the end of Q2 2021
- Superinvestors holding
- 0
- At the end of Q2 2021
Superinvestors holding CNST, Q2 2021
No superinvestor reported holding CNST at the end of Q2 2021.
Latest insider trades
Open-market purchases and sales by Constellation Pharmaceuticals Inc insiders from Form 4, newest first.
No open-market purchases or sales by Constellation Pharmaceuticals Inc insiders are on file.
Top 10 13F holders, Q2 2021
The largest institutional positions in Constellation Pharmaceuticals Inc at the end of Q2 2021; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 3,210,000 | $108.5M | 1.89% | +260,000+8.8% | Added |
| BlackRock Inc. | 2,781,344 | $94.0M | 0.00% | +131,642+5.0% | Added |
| The Column Group LLC | 2,626,631 | $88.8M | 12.57% | 00.0% | Unchanged |
| Ponoi Management, LLC | 1,880,623 | $63.6M | 35.32% | 00.0% | Unchanged |
| Magnetar Financial LLC | 1,828,482 | $61.8M | 0.63% | +1,828,482 | New |
| Omni Partners US LLC | 1,815,117 | $61.4M | 2.71% | +1,815,117 | New |
| Deerfield Management Company, L.P. (Series C) | 1,601,427 | $54.1M | 0.96% | −107,530−6.3% | Reduced |
| State Street Corp | 1,590,606 | $53.8M | 0.00% | −603,808−27.5% | Reduced |
| Versor Investments LP | 1,588,845 | $53.7M | 1.89% | +1,588,845 | New |
| Ponoi II Management, LLC | 1,574,229 | $53.2M | 43.12% | 00.0% | Unchanged |